Navigation Links
Scientists ID Pathway That Makes Antipsychotic Drugs Work
Date:8/26/2008

Finding could aid drug manufacturers in development of new therapies

TUESDAY, Aug. 26 (HealthDay News) -- New findings that antipsychotic drugs may not work as scientists have assumed could lead to changes in how the drugs are developed and prescribed, say Duke University Medical Center researchers.

Antipsychotic drugs used to treat schizophrenia and other mental health problems target the D2 receptor inside cells. The Duke researchers found that the biochemical pathways that are linked to this receptor -- and along which the drugs deliver their effects -- may function differently than previously believed.

The Duke team focused on two main pathways linked to the D2 receptor -- the G-protein-dependent signaling pathway and the beta-arrestin pathway. Most antipsychotic drugs target the G-protein signaling that occurs at the D2 receptor. Only recently has beta-arrestin been shown to play a role.

The researchers were surprised by what they found.

"Our work showed that all nine antipsychotic drugs we examined uniformly and more potently block the beta-arrestin pathway downstream of the D2 dopamine receptor," lead author Bernard Masri, a postdoctoral researcher in the department of cell biology, said in a Duke news release.

But the drugs had a range of effects on the G-protein pathway.

"Some activated it, some blocked the G side totally, some blocked it only 50 percent -- the drugs had different profiles for the G-protein pathway," Masri said.

"So, with this new information, drug manufacturers would want to make sure new compounds for antipsychotic use block the beta-arrestin pathway," he noted.

The study was published in this week's issue of the journal Proceedings of the National Academy of Sciences.

More information

The U.S. National Institute of Mental Health has more about medications.



-- Robert Preidt



SOURCE: Duke University Medical Center, news release, Aug. 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. UT Southwestern scientists discover leptin can also aid type 1 diabetics
2. Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find
3. By amplifying cell death signals, scientists make precancerous cells self-destruct
4. NIH scientists find a novel mechanism that controls the development of autoimmunity
5. Scientists use old enemy to K.O. cancer
6. Distinguished Cardiologists and Scientists Honored With 2008 International Academy of Cardiology Award
7. CSHL neuroscientists glimpse how the brain decides what to believe
8. Scientists measure connection between the built environment and obesity in baby boomers
9. Gladstone scientists identify single microRNA that controls blood vessel development
10. Scientists identify another piece of the weight-control puzzle
11. Scientists Create Mice Resistant to Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign ... for the Access to Contraception for Women Servicemembers and Dependents Act of 2017. ... (D-CA), will help to ensure that all members of the Armed Forces receive ...
(Date:4/28/2017)... ... , ... It's not always common knowledge whether or not a certain sickness ... to whether or not they are contagious, and most people don't know the answer ... took a look into the matter. , They discovered that the main reason ...
(Date:4/28/2017)... UT (PRWEB) , ... April 28, 2017 , ... Beginning ... some of their formulas. This begins with the popular ClearLungs Extra Strength formula. To ... be changing the formula in the following ways:, , Removal ...
(Date:4/28/2017)... ... April 28, 2017 , ... Getting enough sleep affects much more than energy – it ... 19 hours without sleep can compromise motor reaction time, which can increase the risk of ... is sharing the following tips from the NSF to help you sleep better and feel ...
(Date:4/28/2017)... ... April 28, 2017 , ... Date aired: April ... “Computers are everywhere and they’re here to stay,” said Sharon Kleyne on her ... Your Health on Voice America sponsored by Nature’s Tears® EyeMist®. So she was ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)... 2017 The Global Effective Microorganisms (EM) ... report has covered and analysed the potential of Global Effective ... size, shares and growth factors. The report identifies and analyses ... in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, spread ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: